Medikamentöse Therapie nichtmelanozytärer epithelialer Tumore
作者： M. Schlaak , W. von Bartenwerffer , C. Mauch
DOI: 10.1007/S00105-010-2044-2
关键词:
摘要: Basal cell carcinoma, actinic keratosis as a carcinoma in situ and squamous are classified non-melanoma epithelial skin cancers. These forms of cancer thought to be the most common cancers worldwide with rising incidences. In past years new insights into pathogenesis have been gained. Through knowledge pathologic pathways, treatment options become available. This review summarizes recent advantages cancer.
springer.com
sci-hub.se 参考文章(46)
L Frank Glass, Sarah M Bair, Erica Smithberger, Basil S Cherpelis, Christina Marquez, Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients. Journal of Drugs in Dermatology. ,vol. 9, pp. 753- 758 ,(2010)
C. Serra-Guillen, E. Nagore, L. Hueso, B. Llombart, C. Requena, O. Sanmartín, R. Botella-Estrada, C. Guillen, A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate British Journal of Dermatology. ,vol. 164, pp. 429- 433 ,(2011) , 10.1111/J.1365-2133.2010.10098.X
James E. Cleaver, Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nature Reviews Cancer. ,vol. 5, pp. 564- 573 ,(2005) , 10.1038/NRC1652
Thomas Ruzicka, Ronald G. J. Frank, Ullrich Munzel, Mosaad Megahed, Harald Gollnick, Carlos Guillen Barona, Joachim Maus, Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe European Journal of Dermatology. ,vol. 18, pp. 677- 682 ,(2008) , 10.1684/EJD.2008.0519
Greg Siller, Robert Rosen, Michael Freeman, Peter Welburn, Janelle Katsamas, Steven M Ogbourne, PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial. Australasian Journal of Dermatology. ,vol. 51, pp. 99- 105 ,(2010) , 10.1111/J.1440-0960.2010.00626.X
Glen J. Weiss, Mitesh J. Borad, Christine L. Hann, Julie R. Brahmer, Howard M. Mackey, Bertram L. Lum, Walter C. Darbonne, James C. Marsters, Frederic J. de Sauvage, Jennifer A. Low, Daniel D. Von Hoff, Patricia M. LoRusso, Charles M. Rudin, Josina C. Reddy, Robert L. Yauch, Raoul Tibes, Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma New England Journal of Medicine. ,vol. 361, pp. 1164- 1172 ,(2009) , 10.1056/NEJMOA0905360
M Reuschenbach, T Tran, F Faulstich, W Hartschuh, S Vinokurova, M Kloor, E Krautkrämer, M Zeier, M von Knebel Doeberitz, C Sommerer, High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients British Journal of Cancer. ,vol. 104, pp. 1334- 1341 ,(2011) , 10.1038/BJC.2011.95
Scott M Schlauder, Kenneth B Calder, Patricia Moody, Michael B Morgan, HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma. American Journal of Dermatopathology. ,vol. 29, pp. 559- 563 ,(2007) , 10.1097/DAD.0B013E318159BF95
Elke Bergmann-Leitner, Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner] Current Pharmaceutical Design. ,vol. 15, pp. 730- 731 ,(2005) , 10.2174/138161208784246207
Magdalena Skipper, Cancer genetics: A guardian and a suppressor Nature Reviews Genetics. ,vol. 5, pp. 564- 564 ,(2004) , 10.1038/NRG1416